Skip to content

Slovakia attains ECRIN full Membership

1minút, 39sekúnd

On January 27, 2025 the ECRIN Assembly of Members voted in favour of Slovakia obtaining ECRIN full membership. Slovakia has been an ECRIN Observer since 2018. Slovakia is represented by its national scientific partner SLOVACRIN (the Slovak Clinical Research Infrastructure) headquartered at the Faculty of Medicine of the Pavol Jozef Šafárik University in Košice. 

SLOVACRIN is the national research infrastructure for non-commercial clinical trials in Slovakia.  It represents a national distributed research infrastructure connecting hospitals, universities and scientific institutions involved in academic clinical research. The aim of the national infrastructure is to increase the number and quality of academically initiated clinical trials in Slovakia using the available capacity and expertise, knowledge, research, and development in the field of medical sciences and to help build a network of clinical trial units.

Through full ECRIN Membership SLOVACRIN gains access to the full host of ECRIN services thus providing additional support to the national research landscape and a stronger foothold in Europe.

SlovaCRIN has been working since its inception to define its place in the national research landscape and it worked successfully to be included in the Roadmap of Research Infrastructures Slovakia VI Roadmap 2020-2030 where it has been listed since 2021. A key document for the Slovak Republic in the field of research infrastructures.

About ECRIN

ECRIN is the European Clinical Research Infrastructure Network, a public, nonprofit organisation that focuses on investigator initiated multinational clinical studies as well as clinical studies initiated by SMEs. It provides sponsors and investigators with advice, management services and tools to navigate Europe’s fragmented health and legal systems on clinical trials. ECRIN has national scientific partners in 13 countries covering more than 360 million citizens. Multi-country clinical studies mean greater access to patients, resources, and expertise, and in turn, faster and potentially more robust results.

Contact information

For more information on SLOVACRIN visit the SLOVACRIN website or contact simona.sonderlichova@upjs.sk.

For more information on ECRIN visit the ECRIN website or contact ECRIN via mail at media@ecrin.org.


Study at UPJŠ